Anja Seckinger

Vrije Universiteit Brussel — Belgium

Medicine · Health Sciences

44h-index7.2kcitations282works0.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Myeloma Research and Treatments(197), Protein Degradation and Inhibitors(72), Mesenchymal stem cell research(24), Peptidase Inhibition and Analysis(24), Ubiquitin and proteasome pathways(21)

Publications282 total

1512O NI-1801, a mesothelin x CD47 bispecific antibody: Safety and activity as single agent and in combination with pembrolizumab, in heavily pretreated (≥ 4 prior lines) mesothelin expressing platinum-resistant epithelial ovarian cancer patients
Annals of Oncology·2025
CO198 Outcomes Measured in Multiple Myeloma Trials in the Past 10 Years: Focus on Minimal Residual Disease and Therapy Response
Value in Health·2025
Minimal Residual Disease–Based End Point for Accelerated Assessment of Clinical Trials in Multiple Myeloma: A Pooled Analysis of Individual Patient Data From Multiple Randomized Trials
Journal of Clinical Oncology·2025· 26 citedOpen Access
Correction: Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma
Journal of Hematology & Oncology·2025Open Access
Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma
Journal of Hematology & Oncology·2024· 3 citedOpen Access
Molecular Long-Term Analysis of the GMMG-HD4 Trial in Multiple Myeloma—Patterns of Association of Chromosomal Aberrations with Response and Proliferation Determining Survival in Selecting Treatments in View of Limited Resources in Low- and Middle-Income Countries
International Journal of Molecular Sciences·2024· 1 citedOpen Access
Supplementary Table 1 from Modeling Myeloma Dissemination <i>In Vitro</i> with hMSC-interacting Subpopulations of INA-6 Cells and Their Aggregation/Detachment Dynamics
2024Open Access
Supplementary Video 3 from Modeling Myeloma Dissemination <i>In Vitro</i> with hMSC-interacting Subpopulations of INA-6 Cells and Their Aggregation/Detachment Dynamics
2024Open Access
FIGURE 4 from Modeling Myeloma Dissemination <i>In Vitro</i> with hMSC-interacting Subpopulations of INA-6 Cells and Their Aggregation/Detachment Dynamics
2024Open Access
FIGURE 5 from Modeling Myeloma Dissemination <i>In Vitro</i> with hMSC-interacting Subpopulations of INA-6 Cells and Their Aggregation/Detachment Dynamics
2024Open Access
Supplementary Table 3 from Modeling Myeloma Dissemination <i>In Vitro</i> with hMSC-interacting Subpopulations of INA-6 Cells and Their Aggregation/Detachment Dynamics
2024Open Access
FIGURE 1 from Modeling Myeloma Dissemination <i>In Vitro</i> with hMSC-interacting Subpopulations of INA-6 Cells and Their Aggregation/Detachment Dynamics
2024Open Access
Supplementary Figures 1-8 from Modeling Myeloma Dissemination <i>In Vitro</i> with hMSC-interacting Subpopulations of INA-6 Cells and Their Aggregation/Detachment Dynamics
2024Open Access
FIGURE 3 from Modeling Myeloma Dissemination <i>In Vitro</i> with hMSC-interacting Subpopulations of INA-6 Cells and Their Aggregation/Detachment Dynamics
2024Open Access
FIGURE 2 from Modeling Myeloma Dissemination <i>In Vitro</i> with hMSC-interacting Subpopulations of INA-6 Cells and Their Aggregation/Detachment Dynamics
2024Open Access
Data from Modeling Myeloma Dissemination <i>In Vitro</i> with hMSC-interacting Subpopulations of INA-6 Cells and Their Aggregation/Detachment Dynamics
2024Open Access
Supplementary Video 4 from Modeling Myeloma Dissemination <i>In Vitro</i> with hMSC-interacting Subpopulations of INA-6 Cells and Their Aggregation/Detachment Dynamics
2024Open Access
Supplementary Table 3 from Modeling Myeloma Dissemination <i>In Vitro</i> with hMSC-interacting Subpopulations of INA-6 Cells and Their Aggregation/Detachment Dynamics
2024Open Access
TABLE 1 from Modeling Myeloma Dissemination <i>In Vitro</i> with hMSC-interacting Subpopulations of INA-6 Cells and Their Aggregation/Detachment Dynamics
2024Open Access
FIGURE 4 from Modeling Myeloma Dissemination <i>In Vitro</i> with hMSC-interacting Subpopulations of INA-6 Cells and Their Aggregation/Detachment Dynamics
2024Open Access
page 1 of 15Next →

Frequent Co-authors

Dirk Hose(39), Hartmut Goldschmidt(27), Anthony D. Ho(18), Jens Hillengaß(16), Anna Jauch(16), Thomas Hielscher(12), Kai Neben(10), Axel Benner(10), Jérôme Moreaux(10), Bernard Klein(9), U. Krause(8), Michael Hundemer(8), Marc S. Raab(8), Thierry Rème(8), Uta Bertsch(8), Ute Hegenbart(7), Stefan Schönland(7), Tobias Meißner(7), Martin Granzow(6), Christina Kunz(6)